6-Methyl-2-(p-tolyl)imidazo[1,2-a]pyridine

Catalog No. :
ACKHDG938
CAS No. :
88965-00-8
Molecular Formula :
C15H14N2
Molecular Weight :
222.29

IUPAC Name:6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridine

6-Methyl-2-(p-tolyl)imidazo[1,2-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$97.00Login to see priceIn stockIn stock
100g98%$351.00Login to see priceIn stockIn stock
500g98%$1592.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Methyl-2-(p-tolyl)imidazo[1,2-a]pyridine
IUPAC Name6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridine
MDL No.MFCD00444739
Molecular FormulaC15H14N2
Molecular Weight222.29
SMILESCC1=CC=C(C2=CN3C=C(C)C=CC3=N2)C=C1
InChI KeyAWEWSJJCANQFRB-UHFFFAOYSA-N
Synonym6-methyl-2-(4-methylphenyl)imidazo[1,2-alpha]pyridine;6-Methyl-2-(4-methylphenyl-imidazo[1,2-a]pyridine;6-METHYL-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDINE;ZolpidemTartrate1.6-Methyl-2-(4-Methylphenyl)Imidazo[1,2-A]Pyridine;IMIDAZO[1,2-A]PYRIDINE, 6-METHYL-2-(4-METHYLPHENYL)-;6-METHYL-2-P-TOLY-IIDAZOLE(1,2)PYRIDINE;6-methyl-2-p-tolylimidazo[1,2-a]pyridin;Zolpidem Impurity 32
CAS No.88965-00-8
PubChem CID667720

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKHDG938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKHDG938 route product structure diagram
    ACKHDG93888965-00-8 In Stock
Inquiry

2. ACKHDG938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKHDG938 route product structure diagram
    ACKHDG93888965-00-8 In Stock
Inquiry

Comments (0)